comparemela.com

Latest Breaking News On - Klinikum dessau - Page 2 : comparemela.com

European Commission Approves Secukinumab for Hidradenitis Suppurativa

The approval makes the drug Europe’s first and only interleukin (IL)-17A inhibitor approved for the condition.

Klinikum dessauEuropean commissionBrandenburg medical schoolEuropean hidradenitis suppurativa foundationHidradenitis suppurativa

Novartis : receives European approval for Cosentyx® as first and only IL-17A inhibitor for hidradenitis suppurativa

Cosentyx® is the first new biologic treatment for hidradenitis suppurativa in nearly a decade, offering clinically meaningful results across the most debilitating. | June 1, 2023

Trinidad and tobagoUnited statesDermatol venereolHaseeb ahmadJulie masowSatoshi sugimotoHidradenitis suppurativaMac mahonRichard jarvisParag mahantiMichael meoMary carmichaelSamir shahIsabella zinckKlinikum dessauNicole zinsli somm

vimarsana © 2020. All Rights Reserved.